Paying For Personalized Medicine: Medicare CED Approach Advised

If CMS proceeds with a national coverage determination on diagnostics for patient-specific drug therapy, it should consider a Coverage with Evidence Development approach, the Personalized Medicine Coalition suggests in Sept. 26 comments to the agency